* May 05, 2024 According to Total H Index. BETA VERSION. Subject field ranking in world, region, country and university is beta version since subject field 'others' (377.018) scientists profile whose branch cannot be determined, not yet edited or determined) is excluded, so the ranking will change as the others fields are edited. Please note that. See also: University Subject Rankings
AD Scientific Index - Subject Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution | Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
1 | 129 | 140 | 310 |
|
United States | National Cancer Institute |
Others
|
214 | 99 | 0.463 | 1439 | 883 | 0.614 | 190979 | 47692 | 0.250 |
2 | 278 | 301 | 726 |
|
United States | National Cancer Institute |
Others
kidney cancer | VHL | fumarate hydratase | FLCN | MET | |
186 | 89 | 0.478 | 671 | 434 | 0.647 | 136378 | 51824 | 0.380 |
3 | 573 | 619 | 1349 |
|
United States | National Cancer Institute |
Others
Cancer | |
157 | 101 | 0.643 | 473 | 391 | 0.827 | 111212 | 52274 | 0.470 |
4 | 610 | 657 | 1424 |
|
United States | National Cancer Institute |
Others
HPV epidemiology | |
155 | 74 | 0.477 | 538 | 367 | 0.682 | 99490 | 30904 | 0.311 |
5 | 1199 | 1289 | 2591 |
|
United States | National Cancer Institute |
Medical and Health Sciences / Medical Biochemistry
medicine | biochemistry | |
134 | 87 | 0.649 | 466 | 367 | 0.788 | 87863 | 42641 | 0.485 |
6 | 1626 | 1745 | 3497 |
|
United States | National Cancer Institute |
Others
cancer epidemiology | low-dose protracted occupational radiation | radiofrequency radiation and mobile telephone use | residential | |
125 | 65 | 0.520 | 426 | 288 | 0.676 | 107140 | 38371 | 0.358 |
7 | 1689 | 1812 | 3625 |
|
United States | National Cancer Institute |
Medical and Health Sciences / Medical Genetics
Human Genetics | cancer | |
124 | 63 | 0.508 | 377 | 203 | 0.538 | 89530 | 16742 | 0.187 |
8 | 1818 | 1954 | 3880 |
|
United States | National Cancer Institute |
Others
cancer | occupation | |
122 | 59 | 0.484 | 461 | 274 | 0.594 | 50160 | 12993 | 0.259 |
9 | 1968 | 2124 | 4184 |
|
United States | National Cancer Institute |
Others
Tumor microenvironment | extracellular matrix | |
120 | 34 | 0.283 | 272 | 116 | 0.426 | 55402 | 5030 | 0.091 |
10 | 2069 | 2231 | 4402 |
|
United States | National Cancer Institute |
Others
chemical biology | |
118 | 59 | 0.500 | 300 | 194 | 0.647 | 52554 | 12835 | 0.244 |
Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||||||||
11 | 2130 | 2295 | 4538 |
|
United States | National Cancer Institute |
Others
Behavioral and psychosocial oncology | patient-reported outcomes research | |
117 | 63 | 0.538 | 392 | 283 | 0.722 | 46814 | 16096 | 0.344 |
12 | 2410 | 2593 | 5136 |
|
United States | National Cancer Institute |
Engineering & Technology / Computer Science
Prostate cancer | focal therapy | artificial intelligence | molecular imaging | PSMA | |
113 | 79 | 0.699 | 524 | 428 | 0.817 | 49970 | 28638 | 0.573 |
13 | 2604 | 2807 | 5558 |
|
United States | National Cancer Institute |
Others
cancer | HIV | organ transplantation | |
111 | 69 | 0.622 | 334 | 271 | 0.811 | 47738 | 18385 | 0.385 |
14 | 2892 | 3123 | 6184 |
|
United States | National Cancer Institute |
Others
|
108 | 65 | 0.602 | 222 | 171 | 0.770 | 52418 | 14373 | 0.274 |
15 | 4244 | 4625 | 9206 |
|
United States | National Cancer Institute |
Others
|
97 | 77 | 0.794 | 327 | 317 | 0.969 | 38756 | 23208 | 0.599 |
16 | 5032 | 5488 | 10950 |
|
United States | National Cancer Institute |
Others
pancreatic cancer | |
93 | 53 | 0.570 | 209 | 184 | 0.880 | 24904 | 10314 | 0.414 |
17 | 5444 | 5943 | 11956 |
|
United States | National Cancer Institute |
Medical and Health Sciences / Biochemistry
Membrane Biochemistry | Transport Biochemsitry | Multidrug resistance | |
91 | 47 | 0.516 | 257 | 191 | 0.743 | 37934 | 9808 | 0.259 |
18 | 6015 | 6573 | 13215 |
|
United States | National Cancer Institute |
Others
Cancer | Aging | Cell Cycle | Drug Discovery | |
88 | 61 | 0.693 | 174 | 135 | 0.776 | 48493 | 22147 | 0.457 |
19 | 6306 | 6892 | 13957 |
|
United States | National Cancer Institute |
Others
Leukemia | Lymphoma | Flow Cytometry | |
87 | 49 | 0.563 | 252 | 153 | 0.607 | 37292 | 15528 | 0.416 |
20 | 6704 | 7322 | 14853 |
|
United States | National Cancer Institute |
Others
liver | cancer | immunology | immunotherapy | |
85 | 66 | 0.776 | 229 | 175 | 0.764 | 55576 | 29727 | 0.535 |
21 | 6851 | 7480 | 15216 |
|
United States | National Cancer Institute |
Others
longitudinal data analysis | biomarker analyses | chemical mixtures | epidemiologic methods | cancer research | |
85 | 46 | 0.541 | 290 | 190 | 0.655 | 30993 | 8821 | 0.285 |
22 | 7557 | 8254 | 16820 |
|
United States | National Cancer Institute |
Natural Sciences / Molecular Biology & Genetics
breast cancer | cell signaling | stem cells | mammary gland development | embryonic development | |
83 | 28 | 0.337 | 252 | 73 | 0.290 | 25789 | 3607 | 0.140 |
23 | 8304 | 9098 | 18694 |
|
United States | National Cancer Institute |
Others
Population-based surveillance | |
80 | 49 | 0.613 | 155 | 122 | 0.787 | 94481 | 34220 | 0.362 |
24 | 8521 | 9339 | 19140 |
|
United States | National Cancer Institute |
Medical and Health Sciences / Epidemiology and Public Health
Clinical epidemiology | second cancers | ionizing radiation | epidemiological methods | |
79 | 64 | 0.810 | 199 | 176 | 0.884 | 114346 | 48808 | 0.427 |
25 | 8914 | 9778 | 20157 |
|
United States | National Cancer Institute |
Medical and Health Sciences / Pediatrics and Child Health
cancer etiology | telomere biology | pediatrics | bone marrow failure. | |
78 | 55 | 0.705 | 211 | 182 | 0.863 | 23005 | 11724 | 0.510 |
26 | 10084 | 11091 | 23163 |
|
United States | National Cancer Institute |
Others
cancer | vaccine | radiation | chemotherapy | |
75 | 46 | 0.613 | 166 | 116 | 0.699 | 19102 | 8259 | 0.432 |
27 | 10404 | 11443 | 23945 |
|
United States | National Cancer Institute |
Natural Sciences / Mathematical Sciences
Statistics | Genetics | |
74 | 53 | 0.716 | 184 | 145 | 0.788 | 24165 | 8859 | 0.367 |
28 | 11539 | 12710 | 26794 |
|
United States | National Cancer Institute |
Others
|
72 | 38 | 0.528 | 216 | 125 | 0.579 | 20888 | 5642 | 0.270 |
29 | 11866 | 13074 | 27642 |
|
United States | National Cancer Institute |
Natural Sciences / Biological Science
Physical Activity | Physiological Ecology | Built Environment | |
71 | 47 | 0.662 | 171 | 135 | 0.789 | 30306 | 10655 | 0.352 |
30 | 13357 | 14778 | 31586 |
|
United States | National Cancer Institute |
Others
Cancer Diagnosis and Treatment | |
68 | 46 | 0.676 | 125 | 85 | 0.680 | 22363 | 12754 | 0.570 |
A New and Different Feature!!!! University Subject Rankings in 12 subjects:Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc. |
||||||||||||||||
31 | 13483 | 14918 | 31919 |
|
United States | National Cancer Institute |
Others
Computational structure biology | |
68 | 40 | 0.588 | 146 | 111 | 0.760 | 18847 | 5746 | 0.305 |
32 | 13654 | 15108 | 32333 |
|
United States | National Cancer Institute |
Others
growth factor signaling | receptor tyrosine kinases | cancer research | |
68 | 31 | 0.456 | 143 | 74 | 0.517 | 23018 | 5353 | 0.233 |
33 | 13714 | 15180 | 32450 |
|
United States | National Cancer Institute |
Others
lung cancer growth factors | |
68 | 22 | 0.324 | 249 | 62 | 0.249 | 19456 | 2269 | 0.117 |
34 | 13887 | 15372 | 33015 |
|
United States | National Cancer Institute |
Natural Sciences / Mathematical Sciences
Statistics | Survival Analysis | Cancer | Prevalence | |
67 | 45 | 0.672 | 118 | 92 | 0.780 | 30973 | 17995 | 0.581 |
35 | 13947 | 15442 | 33220 |
|
United States | National Cancer Institute |
Engineering & Technology / Metallurgical & Materials Engineering
soft materials | drug delivery | self-assembly | cell-penetrating peptides | peptide design synthesis & characterization | |
67 | 42 | 0.627 | 121 | 102 | 0.843 | 16272 | 5590 | 0.344 |
36 | 14939 | 16554 | 35745 |
|
United States | National Cancer Institute |
Others
Cancer | HIV | Epidemiology | Surveillance | |
65 | 55 | 0.846 | 135 | 125 | 0.926 | 13601 | 8596 | 0.632 |
37 | 15063 | 16688 | 36119 |
|
United States | National Cancer Institute |
Others
cancer | |
65 | 46 | 0.708 | 198 | 142 | 0.717 | 20701 | 12024 | 0.581 |
38 | 15639 | 17352 | 37690 |
|
United States | National Cancer Institute |
Others
|
64 | 48 | 0.750 | 172 | 136 | 0.791 | 13900 | 7991 | 0.575 |
39 | 15956 | 17712 | 38548 |
|
United States | National Cancer Institute |
Others
Radiation | genetic susceptibility | second cancer | |
64 | 36 | 0.563 | 138 | 81 | 0.587 | 16698 | 4095 | 0.245 |
40 | 17190 | 19093 | 41922 |
|
United States | National Cancer Institute |
Others
Cancer Research | Epidemiology | Biostatistical Methods | |
62 | 41 | 0.661 | 92 | 73 | 0.793 | 38847 | 15730 | 0.405 |
41 | 17548 | 19501 | 42869 |
|
United States | National Cancer Institute |
Others
HIV retroviruses | |
62 | 29 | 0.468 | 125 | 70 | 0.560 | 11381 | 2650 | 0.233 |
42 | 19533 | 21726 | 48318 |
|
United States | National Cancer Institute |
Others
virology | vaccines | |
59 | 42 | 0.712 | 99 | 82 | 0.828 | 16730 | 5829 | 0.348 |
43 | 19580 | 21781 | 48460 |
|
United States | National Cancer Institute |
Others
Health Communication | Informatics | Cancer Prevention and Control | |
59 | 40 | 0.678 | 140 | 102 | 0.729 | 16744 | 7716 | 0.461 |
44 | 20228 | 22541 | 50176 |
|
United States | National Cancer Institute |
Medical and Health Sciences / Epidemiology and Public Health
Epidemiology of prostate cancer and esophageal adenocarcinoma | |
58 | 47 | 0.810 | 147 | 132 | 0.898 | 15225 | 8797 | 0.578 |
45 | 20938 | 23364 | 52184 |
|
United States | National Cancer Institute |
Others
|
58 | 24 | 0.414 | 88 | 43 | 0.489 | 11794 | 2150 | 0.182 |
46 | 21237 | 23702 | 53146 |
|
United States | National Cancer Institute |
Others
|
57 | 41 | 0.719 | 96 | 67 | 0.698 | 14879 | 5441 | 0.366 |
47 | 21994 | 24564 | 55399 |
|
United States | National Cancer Institute |
Others
Ovarian cancer etiology | Endometrial cancer etiology | Hormonal etiology of cancer | |
56 | 44 | 0.786 | 143 | 129 | 0.902 | 12817 | 9521 | 0.743 |
48 | 22119 | 24707 | 55828 |
|
United States | National Cancer Institute |
Others
medical uncertainty | risk communication | shared decision making | |
56 | 40 | 0.714 | 129 | 117 | 0.907 | 12918 | 7923 | 0.613 |
49 | 22146 | 24736 | 55886 |
|
United States | National Cancer Institute |
Others
|
56 | 40 | 0.714 | 78 | 68 | 0.872 | 30028 | 10782 | 0.359 |
50 | 22696 | 25346 | 57409 |
|
United States | National Cancer Institute |
Natural Sciences / Biological Science
|
56 | 27 | 0.482 | 102 | 54 | 0.529 | 18446 | 5352 | 0.290 |